Blog

Chromadex v. Elysium Health – It’s Only Natural!
Blog

“Inequitable Conduct: Refresher and Update” Panel on March 16
Blog

PTO Expands the Scope of the Immunotherapy Pilot Program
Blog

Moderna to Pfizer: “The Pandemic is Over”
Blog

Tillis Bill Tries to Fix Section 101
Blog

CareDx v. Natera – The Broad Road to Patent Ineligibility
Blog

Former USPTO Official Drew Hirshfeld Joins Schwegman Lundberg & Woessner as Principal
Blog

Novartis v. Accord Redux – Panel 2 Reverses Panel 1
Blog

The Solicitor’s Holistic Approach to the Mayo/Alice Analysis in American Axle
Blog

Almirall v. Amneal Pharmaceuticals – Negative Limitations II
Blog

Intellectual Property in Russia
Blog
